Diagnosis and Outcomes of Placental Accretism
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a condition called placenta accreta, which happens when the placenta attaches too deeply into the wall of the uterus. The main goal of the study is to see how well current methods can diagnose this condition and to understand the different management strategies that can be used when it is suspected. The researchers want to learn more about the possible complications for mothers during and after pregnancy, depending on how the condition is managed.
To participate in this study, women need to be between 18 and 44 years old and must be pregnant with a suspicion of placenta accreta. There aren’t any specific exclusions for this trial, so if you meet the age requirement and have been told you might have this condition, you could be eligible. If you decide to join, you’ll be contributing to important research that could help improve care for future patients with similar concerns.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 years and 44 years
- • Pregnant women with suspected placental accretism
- • Acquisition of informed consent form
- Exclusion Criteria:
- • None
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Forlì, , Italy
Reggio Emilia, , Italy
Bologna, , Italy
Parma, , Italy
Cesena, Forlì Cesena, Italy
Forlì, Forlì Cesena, Italy
Modena, , Italy
Rimini, , Italy
Cesena, , Italy
Patients applied
Trial Officials
Gianluigi Pilu, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported